GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File photo Acquire Licensing Rights Sept 28 – GSK (GSK.L) on Thursday lifted its...
Frankfurt, November 7 (Reuters)-Alzheimer’s disease drug developer AC immunity (ACIU.O) In an interview with a German magazine, the company’s CEO predicts that the number of families...
Recent Comments